Literature DB >> 2438335

Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.

S Ozaki, J A Berzofsky.   

Abstract

We developed antibody conjugates by covalently coupling antibodies against mouse mu-chain and monoclonal antibodies against nominal antigen, myoglobin, as a tool for antigen presentation and as a model of specific presentation of antigen by antigen-specific B cells and T-B interaction. In the presence of the antibody conjugates, myoglobin-specific Iad-restricted cloned T cells proliferated at 1000-fold lower concentration of myoglobin than the stimulatory concentration without the conjugates. This enhanced presentation was observed only when Iad spleen cells were 1000 R-irradiated but not 3300 R-irradiated, consistent with B cell presentation. The simple mixture of each component of the conjugates had no enhancement effects. The conjugates per se had no mitogenic effects on either splenic B cells or the cloned T cells at concentrations employed for antigen presentation. The conjugates reduced the number of antigen-presenting cells required for the maximal response but did not change the kinetics of response. The enhanced presentation by the conjugates required a genetically restricted interaction with B cells. Antigen specificity of the enhanced presentation was confirmed by using various T cell clones or lines with different antigen specificities and different conjugates constructed with monoclonal antibodies of known epitope specificity. The enhanced presentation was significantly inhibited by competition with exogenous mouse IgM or anti-mouse mu-chain but was not significantly inhibited by monoclonal antibodies against Fc receptor. Thus, conjugate-coated B cells serve as models for myoglobin-specific B cells in that they can take up specific antigens at extremely low concentration and can present the antigen to specific T cells. This model system can be applied to any antigen and any species without the need to develop antigen-specific B cell clones, which is not yet possible for most antigens and species of experimental animals. This system allowed us to investigate the relationship between T cell epitope and B cell epitope when these cells interact with each other in an antigen-specific and Ia-restricted manner. Experiments using antibody conjugates of different monoclonal antibodies against myoglobin and various myoglobin-specific cloned T cells of known antigen specificity revealed that there are some particular combinations in which much more limited enhancement of antigen presentation is observed.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438335

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Targeting of T-B interaction using heteroconjugate antibody.

Authors:  J L Davignon; M Vallin-Davignon; P L Cohen; R A Eisenberg
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  Mapping major and minor T-cell epitopes in vitro and their immunogenic or tolerogenic effect in vivo in non-human primates.

Authors:  P R Walker; R Smerdon; J Haron; T Lehner
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

3.  Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology.

Authors:  D P Harris; H M Vordermeier; A Arya; K Bogdan; C Moreno; J Ivanyi
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Thyroxine-binding antibodies inhibit T cell recognition of a pathogenic thyroglobulin epitope.

Authors:  Yang D Dai; Petros Eliades; Karen A Carayanniotis; Daniel J McCormick; Yi-Chi M Kong; Vassiliki Magafa; Paul Cordopatis; Peggy Lymberi; George Carayanniotis
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics.

Authors:  Siva Charan Devanaboyina; Sandra M Lynch; Raimund J Ober; Sripad Ram; Dongyoung Kim; Alberto Puig-Canto; Shannon Breen; Srinath Kasturirangan; Susan Fowler; Li Peng; Haihong Zhong; Lutz Jermutus; Herren Wu; Carl Webster; E Sally Ward; Changshou Gao
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

Review 6.  Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.

Authors:  J A Berzofsky
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.

Authors:  J Arvieux; H Yssel; M G Colomb
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

8.  Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

Authors:  Laura Rivino; Emmanuelle A P Kumaran; Vojislav Jovanovic; Karen Nadua; En Wei Teo; Shyue Wei Pang; Guo Hui Teo; Victor Chih Hao Gan; David C Lye; Yee Sin Leo; Brendon J Hanson; Kenneth G C Smith; Antonio Bertoletti; David M Kemeny; Paul A MacAry
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus.

Authors:  G Riemekasten; C Weiss; S Schneider; A Thiel; A Bruns; F Schumann; S Bläss; G-R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

10.  Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Authors:  Jinsong Zhang; S Munir Alam; Hilary Bouton-Verville; Yao Chen; Amanda Newman; Shelley Stewart; Frederick H Jaeger; David C Montefiori; S Moses Dennison; Barton F Haynes; Laurent Verkoczy
Journal:  J Immunol       Date:  2014-01-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.